Answers are grounded in this paper and cite their sources.
Introduction: The question of how financial considerations influence medical decision-making is coming to a head in cancer medicine, as cancer medicine is getting more expensive and extensive. As the debate continues, empirical data on specific decision-making situations that are influenced by financial consideration and on the characterisation of financial influence in cancer medicine remain scarce. Methods: We conducted a qualitative semistructured interview study with physicians who had experience in controlling and budgeting in different settings of cancer care in Germany. Qualitative content analysis was performed to identify specific decision-making situations in cancer medicine influenced by financial considerations and to characterise the financial influence. Results: n=16 interviews were conducted. We identified 21 medical decision-making situations influenced by financial considerations specific to cancer medicine, which were characterised into four subcategories of financial influence derived from the data: (1) no reimbursement, (2) reimbursement that does not completely cover costs, (3) reimbursement that exceeds the costs and (4) costs covered for treatments with questionable cost-effectiveness. These results imply that medical decisions in cancer medicine could be influenced by financial considerations. Conclusions: The findings support the hypothesis that medical decision-making in cancer medicine can be influenced by financial considerations. They provide specific examples and a characterisation of the influence as starting points for further quantitative studies on the extent of the financial influence and on the possible effect on high-risk patient groups. Further, they underline the need for ethical analysis regarding the implications for quality of care.
No takes yet. Share an insight, caveat, or question.
König et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: